Lexaria Bioscience Corp. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
LEXX Nasdaq 2836 lexariabioscience.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Lexaria Bioscience Corp.

Lexaria Announces Closing of Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds - Sep 9th, 2026 2:15 pm
Lexaria Announces Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds - Sep 8th, 2026 6:00 am
LEXX: Introducing DehydraTECH 3.0 - Sep 8th, 2026 4:15 am
Lexaria to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Sep 4th, 2026 7:20 am
Lexaria Receives USD$2.6 Million Tax Rebate Payment - Sep 1st, 2026 7:15 am
Lexaria Enters a Material Transfer Agreement With PegBio - Aug 13th, 2026 7:00 am
Lexaria Announces Effective Date for Reverse Stock Split - Jul 30th, 2026 9:00 am
LEXX: Dosing Started for Animal & Human GLP-1 Studies - Jul 17th, 2026 9:54 am
Lexaria Updates Business Development - Jul 6th, 2026 7:10 am
Lexaria's Human Study GLP-1-H26-7 Has Begun Dosing on Schedule - Jun 25th, 2026 7:10 am
Lexaria's Animal Study GLP-1-A26-1 Has Begun Dosing on Schedule - Jun 23rd, 2026 7:25 am
GLP-1 'Arms Race' Intensifies as the Addressable Markets Continue to Expand - Jun 17th, 2026 7:25 am
LEXX: Animal & Human GLP-1 Studies Continue - Jun 15th, 2026 3:42 am
Lexaria's Animal Study Examining Next-Generation GLP-1 drugs is Underway - Jun 9th, 2026 7:25 am
Lexaria Attending the BIO International Convention, as Part of a Broader Business Development Program - Jun 3rd, 2026 7:25 am
Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #7 - May 19th, 2026 7:15 am
Lexaria Updates Progress on Human Study #7 - May 5th, 2026 7:10 am
Lexaria Bioscience Launches Ongoing Investor Video Series to Expand Shareholder Communications - May 1st, 2026 7:25 am
Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended - Apr 29th, 2026 7:10 am
Lexaria Launches New Study to Examine Next-Generation GLP-1 Drugs - Apr 23rd, 2026 7:05 am